Atrion Corporation

739.12-1.45-0.20%Vol 7.12K1Y Perf 15.94%
Sep 15th, 2021 16:00 DELAYED
BID736.25 ASK745.40
Open737.48 Previous Close740.57
Pre-Market- After-Market-
 - -%  - -
Target Price
300.00 
Analyst Rating
— 0.00
Potential %
-59.41 
Finscreener Ranking
★★★+     51.36
Insiders Trans % 3/6/12 mo.
-/-/- 
Value Ranking
★★★     51.05
Insiders Value % 3/6/12 mo.
-/-/- 
Growth Ranking
★★★★     59.35
Insiders Shares Cnt. % 3/6/12 mo.
-/-/- 
Income Ranking
★★★+     48.03
Price Range Ratio 52W %
79.38 
Earnings Rating
Buy
Market Cap1.35B 
Earnings Date
8th Nov 2021
Alpha0.01 Standard Deviation0.07
Beta0.08 

Today's Price Range

726.79742.06

52W Range

567.00783.84

5 Year PE Ratio Range

22.6051.40

Summary:

Buy

Technical Indicators: Neutral
Moving Averages: Strong Buy
Performance
1 Week
-0.92%
1 Month
15.18%
3 Months
19.02%
6 Months
10.34%
1 Year
15.94%
3 Years
17.58%
5 Years
74.77%
10 Years
294.42%

TickerPriceChg.Chg.%
ATRI739.12-1.4500-0.20
AAPL149.030.91000.61
GOOG2 904.1236.00001.26
MSFT304.825.03001.68
XOM56.421.84003.37
WFC46.640.59001.28
JNJ165.420.62000.38
FB373.92-2.6100-0.69
GE102.161.78001.77
JPM158.161.09000.69
ProfitabilityValueIndustryS&P 500US Markets
42.60
22.10
30.40
27.30
21.11
RevenueValueIndustryS&P 500US Markets
147.89M
82.13
-0.79
0.91
DividendsValueIndustryS&P 500US Markets
1.03
7.80
11.17
12.89
Payout ratio40.00
Earnings HistoryEstimateReportedSurprise %
Q02 2021-4.88-
Q01 2021-4.22-
Q04 2020-4.02-
Q03 2020-3.95-
Q02 2020-4.68-
Q01 2020-4.79-
Q04 2019-4.33-
Q03 2019-5.15-
Earnings Per EndEstimateRevision %Trend
----
----
----
----
Next Report Date8th Nov 2021
Estimated EPS Next Report-
Estimates Count-
EPS Growth Next 5 Years %-
Volume Overview
Volume7.12K
Shares Outstanding1.83M
Shares Float1.03M
Trades Count382
Dollar Volume5.64M
Avg. Volume7.19K
Avg. Weekly Volume10.33K
Avg. Monthly Volume8.53K
Avg. Quarterly Volume6.89K

Atrion Corporation (NASDAQ: ATRI) stock closed at 739.12 per share at the end of the most recent trading day (a -0.2% change compared to the prior day closing price) with a volume of 7.16K shares and market capitalization of 1.35B. Is a component of indices and it is traded on NASDAQ exchange. The company belongs in the Medical Devices & Instruments industry, Healthcare sector and employs 616 people. Atrion Corporation CEO is David A. Battat.

The one-year performance of Atrion Corporation stock is 15.94%, while year-to-date (YTD) performance is 15.08%. ATRI stock has a five-year performance of 74.77%. Its 52-week range is between 567 and 783.84, which gives ATRI stock a 52-week price range ratio of 79.38%

Atrion Corporation currently has a PE ratio of 44.40, a price-to-book (PB) ratio of 5.67, a price-to-sale (PS) ratio of 9.23, a price to cashflow ratio of 38.70, a PEG ratio of 2.32, a ROA of 11.53%, a ROC of 12.83% and a ROE of 12.84%. The company’s profit margin is 21.11%, its EBITDA margin is 30.40%, and its revenue ttm is $147.89 Million , which makes it $82.13 revenue per share.

Of the last four earnings reports from Atrion Corporation, there were 0 positive earnings surprise and 0 negative earnings surprise. The company has EPS estimate of $0.00 for the next earnings report. Atrion Corporation’s next earnings report date is 08th Nov 2021.

The consensus rating of Wall Street analysts for Atrion Corporation is (0), with a target price of $300, which is -59.41% compared to the current price. The earnings rating for Atrion Corporation stock is Buy (calculated from actual period earnings estimates revision (80% weight) and previous period earnings surprise (20% weight)).

Atrion Corporation has a dividend yield of 1.03% with a dividend per share of $7.80 and a payout ratio of 40.00%.

Atrion Corporation has a Buy technical analysis rating based on Technical Indicators (ADX : 7.51, ATR14 : 16.64, CCI20 : 71.01, Chaikin Money Flow : -0.04, MACD : 25.47, Money Flow Index : 58.39, ROC : 5.29, RSI : 66.87, STOCH (14,3) : 52.69, STOCH RSI : 0.00, UO : 49.82, Williams %R : -47.31), Simple Moving Averages and Exponential Moving Averages.

Aggregated Insider Trades of Atrion Corporation in the last 12-months were: David A. Battat (Option Excercise at a value of $3 228 000), Emile A. Battat (Option Excercise at a value of $5 568 600)

Analyst RatingsCurrent1 M ago3 M ago
Strong Buy
0
0
0 (0.00 %)
Moderate Buy
0
0
0 (0.00 %)
Hold
0
0
0 (0.00 %)
Moderate Sell
0
0
0 (0.00 %)
Strong Sell
0
0
1 (100.00 %)
Summary Rating--Strong Sell
5.00

Atrion Corporation

Atrion Corp develops and manufactures products for medical applications. Its fluid-delivery products contribute the largest proportion of revenue and include valves that can hold and release controlled amounts of fluids or gases and are often used in anesthesia and oncology applications. Atrion's cardiovascular products include the MPS2 Myocardial Protection System, which delivers fluids and medications, mixes drugs, and controls temperature and pressure during open-heart surgery. The cardiovascular business also sells cardiac-surgery vacuum relief valves, inflation devices, and other products used in heart surgery. The firm's ophthalmic products include medical devices that disinfect contact lenses. Atrion generates the majority of revenue in the United States.

CEO: David A. Battat

Telephone: +1 972 390-9800

Address: One Allentown Parkway, Allen 75002, TX, US

Number of employees: 616

Bearish or Bullish?
WeekMonthThree MonthsSix Months

Bearish Bullish

50%50%

Bearish Bullish

100%0%

Bearish Bullish

62%38%

Bearish Bullish

52%48%

News

Stocktwits